El tratamiento fue ms efectivo en pacientes con diabetes tipo II con una corta duracin de la enfermedad
If the CDT is discontinued, the swelling and symptoms return
Acknowledgements Preliminary results were presented at the New York Perinatal Society, New York, NY, 5/28/02, at the Annual Meeting of the Eastern Society for Pediatric Research, Old Greenwich, CT, 3/23/03, and at the Annual Meeting of the Society for Pediatric Research at Seattle, WA, 5/6/03
The agreement was 98.3% (8/8 exposed patients, 49/58 for unexposed patients), with a kappa of 93%
Supplemental Figure 1
Loganathan J, Cohen AC, Kaloupis GM et al (2022) A pilot clinical study to Evaluate Liraglutide-mediated Anti-platelet activity in patients with type-2 Diabetes (ELAID study)